SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 76.92-16.0%9:48 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yard_man who wrote (483)9/16/1998 5:09:00 PM
From: OldAIMGuy  Read Replies (1) of 798
 
Hi T, AIM's sort of DCA with a brain!! As you can see with BSX, it dca'd its way in and out of the stock. However, even if the price was to go up 10X, you'd never sell completely out.

It works around a central value that's initially equal to your original investment. If you are willing to risk $10,000 on an investment, then if the value rises to $13,000, you'd sell off about $2000 of the total shares. That brings your risk back down to within about 10% of your original risk envelope. A drop in value away from the initial set point will trigger similar activity on the Buy side.

I've found that stocks like BSX and other high BETA stocks with lots of momentum players and other short term trading really benefit from the use of AIM. The lack of price stability (driven by market psychology, not fundamentals) has you buy up shares from the folks that are panicing and selling them off to the coat-tail riders. All the time the fundamentals of the company continue to improve.

Best regards, Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext